Literature DB >> 2459778

A Mycobacterium leprae-specific human T cell epitope cross-reactive with an HLA-DR2 peptide.

D C Anderson1, W C van Schooten, M E Barry, A A Janson, T M Buchanan, R R de Vries.   

Abstract

Mycobacterium leprae induces T cell reactivity and protective immunity in the majority of exposed individuals, but the minority that develop leprosy exhibit various types of immunopathology. Thus, the definition of epitopes on M. leprae antigens that are recognized by T cells from different individuals might result in the development of an effective vaccine against leprosy. A sequence from the 65-kD protein of this organism was recognized by two HLA-DR2-restricted, M. leprae-specific helper T cell clones that were derived from a tuberculoid leprosy patient. Synthetic peptides were used to define this epitope as Leu-Gln-Ala-Ala-Pro-Ala-Leu-Asp-Lys-Leu. A similar peptide that was derived from the third hypervariable region of the HLA-DR2 chain, Glu-Gln-Ala-Arg-Ala-Ala-Val-Asp-Thr-Tyr, also activated the same clones. The unexpected cross-reactivity of this M. leprae-specific DR2-restricted T cell epitope with a DR2 peptide may have to be considered in the design of subunit vaccines against leprosy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2459778     DOI: 10.1126/science.2459778

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  28 in total

1.  Distinct recognition by two subsets of T cells of an MHC class II-peptide complex.

Authors:  Zheng Pu; Javier A Carrero; Emil R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-25       Impact factor: 11.205

Review 2.  Heat shock proteins: friend and foe?

Authors:  M Harboe; A J Quayle
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

3.  An idiotypic network model of AIDS immunopathogenesis.

Authors:  G W Hoffmann; T A Kion; M D Grant
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

4.  A postgenomic approach to identification of Mycobacterium leprae-specific peptides as T-cell reagents.

Authors:  H M Dockrell; S Brahmbhatt; B D Robertson; S Britton; U Fruth; N Gebre; M Hunegnaw; R Hussain; R Manandhar; L Murillo; M C Pessolani; P Roche; J L Salgado; E Sampaio; F Shahid; J E Thole; D B Young
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

5.  A comparison of the T cell delayed-type hypersensitivity epitopes of the 19-kD antigens from Mycobacterium tuberculosis and Myco. intracellulare using overlapping synthetic peptides.

Authors:  J C Mackall; G H Bai; D A Rouse; G R Armoa; F Chuidian; J Nair; S L Morris
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

Review 6.  Modulation of the immune response with T-cell epitopes: the ultimate goal for specific immunotherapy of autoimmune disease.

Authors:  P J Fairchild; C J Thorpe; P J Travers; D C Wraith
Journal:  Immunology       Date:  1994-04       Impact factor: 7.397

7.  Cross-reactivity and sequence homology between the 65-kilodalton mycobacterial heat shock protein and human lactoferrin, transferrin, and DR beta subsets of major histocompatibility complex class II molecules.

Authors:  A Aguas; N Esaguy; C E Sunkel; M T Silva
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

Review 8.  Cross-reactivity of T lymphocytes in infection and autoimmunity.

Authors:  Thomas Kamradt; Rudolf Volkmer-Engert
Journal:  Mol Divers       Date:  2004       Impact factor: 2.943

9.  T-cell receptor beta-chain gene usage in the T-cell recognition of Mycobacterium leprae antigens in one tuberculoid leprosy patient.

Authors:  W C van Schooten; J L Ko; N van der Stoep; J B Haanen; L Pickering; R R de Vries; P van den Elsen
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

10.  Antibodies to 65Kd heat-shock protein were elevated in rheumatoid arthritis.

Authors:  A Oda; M Miyata; E Kodama; H Satoh; Y Sato; T Nishimaki; H Nomaguchi; R Kasukawa
Journal:  Clin Rheumatol       Date:  1994-06       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.